Why Trial Results Should Not Be Compared Too Casually Patients often see headlines comparing weight-loss percentages across different medications
Research involving Acetyl L-Carnitine shows promise in Degenerative brain diseases (dementia, alzheimers) Muscle decline from aging (sarcopenia), with 8.4 pound muscle gain in one study on 2 grams/day Enhanced fat reduction (about 4 pounds of fat lost on 2 grams/day in elderly individuals) Angina, heart attack, heart failure Peripheral neuropathy (nerve damage) Sexual dysfunction, like erectile problems Fatigue, especially muscle fatigue, with improved endurance Depression Insulin resistance and high blood sugars Lower cholesterol levels Mightier Mitochondria Mitochondria are your cell power plants and every cell has one, at least one
Shown to regulate serotonin and dopamine levels, BPC-157 has also evidenced positive effects in addressing traumatic brain injury and spinal cord compression [8]
Science 356, 10261030
Until now, patients seeking these peptides have had limited legal options
IGF1 signaling is known to activate the PI3K pathway [8, 38]